This Pharmaceutical Company is Ready to Grow

Aileron Therapeutics Inc. (NASDAQ: ALRN) is a bio pharmaceutical company that focuses on the development of novel oncology drugs. The company‚Äôs recently developed ALRN-6924 treatment is in Phase 2A clinical trials for the treatment of advanced solid tumors. The company is also developing leukemia treatments which are currently in Phase 1B testing. Analysts have been […]